Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions.

MLA

Manzi, Lucio, et al. “Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions.” International Journal of Molecular Sciences, vol. 23, no. 12, June 2022. EBSCOhost, https://doi.org/10.3390/ijms23126762.

APA

Manzi, L., Sepe, N., Migliaccio, W., Lanzoni, L., Iozzino, L., D’Angelo, F., Colarusso, L., Montenegro, S., Palmese, A., D’Hooghe, T., Ulloa-Aguirre, A., Koloda, Y., & Lispi, M. (2022). Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions. International Journal of Molecular Sciences, 23(12). https://doi.org/10.3390/ijms23126762

Chicago

Manzi, Lucio, Nunzio Sepe, Walter Migliaccio, Ludovica Lanzoni, Luisa Iozzino, Fabrizia D’Angelo, Lucia Colarusso, et al. 2022. “Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions.” International Journal of Molecular Sciences 23 (12). doi:10.3390/ijms23126762.